# Elauwit Connection, Inc.: financial statements, quarterly

ELWT · Nasdaq · CIK 2063863 · [Communication](/sectors/communication.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/elwt.md) · [Financials](/companies/elwt/financials.md) · [Filings](/companies/elwt/filings.md) · [Insiders](/companies/elwt/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/elwt/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | period not labelled (2024-12-31) | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | not reported | not reported | [1,885](/filings/0001104659-26-036879.md) | [3,312 d](/filings/0001104659-26-037748.md) | [5,446](/filings/0001104659-26-061490.md) | [5,326](/filings/0001104659-26-098786.md) | [4,777](/filings/0001104659-26-036879.md) | [6,070 d](/filings/0001104659-26-037748.md) | [4,430](/filings/0001104659-26-061490.md) | [2,856](/filings/0001104659-26-098786.md) |
| Cost of revenue | $k | not reported | not reported | [1,671](/filings/0001104659-26-036879.md) | [3,032 d](/filings/0001104659-26-037748.md) | [4,187](/filings/0001104659-26-061490.md) | [4,520](/filings/0001104659-26-098786.md) | [3,360](/filings/0001104659-26-036879.md) | [5,547 d](/filings/0001104659-26-037748.md) | [3,603](/filings/0001104659-26-061490.md) | [2,413](/filings/0001104659-26-098786.md) |
| Gross profit | $k | not reported | not reported | [214](/filings/0001104659-26-036879.md) | [280 d](/filings/0001104659-26-037748.md) | [1,259](/filings/0001104659-26-061490.md) | [806](/filings/0001104659-26-098786.md) | [1,417](/filings/0001104659-26-036879.md) | [523 d](/filings/0001104659-26-037748.md) | [827](/filings/0001104659-26-061490.md) | [443](/filings/0001104659-26-098786.md) |
| Research and development | $k | not reported | not reported | not reported | [0.0 d](/filings/0001104659-26-037748.md) | not reported | not reported | [9.0](/filings/0001104659-26-036879.md) | [10.0 d](/filings/0001104659-26-037748.md) | not reported | not reported |
| Operating income | $k | not reported | not reported | [(881)](/filings/0001104659-26-036879.md) | [(1,037) d](/filings/0001104659-26-037748.md) | [(369)](/filings/0001104659-26-061490.md) | [(739)](/filings/0001104659-26-098786.md) | [(353)](/filings/0001104659-26-036879.md) | [(2,244) d](/filings/0001104659-26-037748.md) | [(2,200)](/filings/0001104659-26-061490.md) | [(3,100)](/filings/0001104659-26-098786.md) |
| Income tax | $k | not reported | not reported | [16.0](/filings/0001104659-26-036879.md) | [(16.0) d](/filings/0001104659-26-037748.md) | [0.0](/filings/0001104659-26-061490.md) | [4.0](/filings/0001104659-26-098786.md) | [1.0](/filings/0001104659-26-036879.md) | not reported | [0.0](/filings/0001104659-26-061490.md) | [4.0](/filings/0001104659-26-098786.md) |
| Net income | $k | [(469)](/filings/0001104659-26-036879.md) | [(944)](/filings/0001104659-26-036879.md) | [(970)](/filings/0001104659-26-036879.md) | [(1,091) d](/filings/0001104659-26-037748.md) | [(442)](/filings/0001104659-26-098786.md) | [(857)](/filings/0001104659-26-098786.md) | [(639)](/filings/0001104659-26-036879.md) | [(2,290) d](/filings/0001104659-26-037748.md) | [(2,162)](/filings/0001104659-26-098786.md) | [(3,131)](/filings/0001104659-26-098786.md) |
| Diluted EPS | $ per share | not reported | not reported | [(0.27)](/filings/0001104659-26-036879.md) | not reported | [(0.09)](/filings/0001104659-26-061490.md) | [(0.17)](/filings/0001104659-26-098786.md) | [(0.13)](/filings/0001104659-26-036879.md) | not reported | [(0.33)](/filings/0001104659-26-061490.md) | [(0.47)](/filings/0001104659-26-098786.md) |
| Basic EPS | $ per share | not reported | not reported | [(0.27)](/filings/0001104659-26-036879.md) | not reported | [(0.09)](/filings/0001104659-26-061490.md) | [(0.17)](/filings/0001104659-26-098786.md) | [(0.13)](/filings/0001104659-26-036879.md) | not reported | [(0.33)](/filings/0001104659-26-061490.md) | [(0.47)](/filings/0001104659-26-098786.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2023-12-31) | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | period not labelled (2024-12-31) | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | [0.3](/filings/0001104659-26-037748.md) | not reported | not reported | [0.8](/filings/0001104659-26-036879.md) | [6.2](/filings/0001104659-26-098786.md) | [3.5](/filings/0001104659-26-061490.md) | [1.2](/filings/0001104659-26-098786.md) |
| Current assets | $m | not reported | not reported | not reported | not reported | [6.7](/filings/0001104659-26-037748.md) | [7.9](/filings/0001104659-26-036879.md) | [8.1](/filings/0001104659-26-036879.md) | [6.2](/filings/0001104659-26-036879.md) | [10.3](/filings/0001104659-26-098786.md) | [8.4](/filings/0001104659-26-061490.md) | [8.2](/filings/0001104659-26-098786.md) |
| Total assets | $m | not reported | not reported | not reported | not reported | [7.7](/filings/0001104659-26-037748.md) | [9.4](/filings/0001104659-26-036879.md) | [9.6](/filings/0001104659-26-036879.md) | [7.7](/filings/0001104659-26-036879.md) | [11.9](/filings/0001104659-26-098786.md) | [9.9](/filings/0001104659-26-061490.md) | [10.1](/filings/0001104659-26-098786.md) |
| Current liabilities | $m | not reported | not reported | not reported | not reported | [9.2](/filings/0001104659-26-037748.md) | not reported | not reported | [10.6](/filings/0001104659-26-036879.md) | [6.2](/filings/0001104659-26-098786.md) | [6.5](/filings/0001104659-26-061490.md) | [9.1](/filings/0001104659-26-098786.md) |
| Total liabilities | $m | not reported | not reported | not reported | not reported | [12.3](/filings/0001104659-26-037748.md) | not reported | not reported | [14.1](/filings/0001104659-26-036879.md) | [7.5](/filings/0001104659-26-098786.md) | [7.6](/filings/0001104659-26-061490.md) | [10.9](/filings/0001104659-26-098786.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | [2.7](/filings/0001104659-26-037748.md) | not reported | not reported | [2.2](/filings/0001104659-26-036879.md) | [1.0](/filings/0001104659-26-037748.md) | not reported | not reported |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | [0.7](/filings/0001104659-26-037748.md) | not reported | not reported | [2.0](/filings/0001104659-26-036879.md) | [1.0](/filings/0001104659-26-037748.md) | not reported | not reported |
| Shareholders' equity | $m | [(6.3)](/filings/0001104659-26-037748.md) | [(7.3)](/filings/0001104659-26-036879.md) | [(8.3)](/filings/0001104659-26-036879.md) | [(3.4)](/filings/0001104659-26-036879.md) | [(4.5)](/filings/0001104659-26-098786.md) | [(4.9)](/filings/0001104659-26-098786.md) | [(5.8)](/filings/0001104659-26-098786.md) | [(6.4)](/filings/0001104659-26-036879.md) | [4.4](/filings/0001104659-26-098786.md) | [2.3](/filings/0001104659-26-098786.md) | [(0.8)](/filings/0001104659-26-098786.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2024-12-31) | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(757) d](/filings/0001104659-26-037748.md) | [(1,536)](/filings/0001104659-26-061490.md) | [86.0 d](/filings/0001104659-26-098786.md) | [142 d](/filings/0001104659-26-036879.md) | [(4,404) d](/filings/0001104659-26-037748.md) | [(2,489)](/filings/0001104659-26-061490.md) | [(2,670) d](/filings/0001104659-26-098786.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities

## Shares

| Line item | Unit | period not labelled (2024-09-30) | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [3,566](/filings/0001104659-26-036879.md) | [5,000](/filings/0001104659-26-061490.md) | [5,000](/filings/0001104659-26-098786.md) | [5,000](/filings/0001104659-26-036879.md) | [6,620](/filings/0001104659-26-061490.md) | [6,620](/filings/0001104659-26-098786.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 6,619,796 at 2026-08-17, from the cover of the [10-Q filed 2026-08-19](/filings/0001104659-26-098786.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:51 ET. No prices; not investment advice.